CVS Health Corp. (CVS) Thursday announced it has expanded its flu and COVID-19 testing and treatment capabilities at approximately 1,600 CVS Pharmacy locations across 37 states.
Patients with flu-like symptoms can now receive a 3-in-1 combo test for Influenza A, Influenza B, and COVID-19 with a single swab.
In select states, including California, Illinois, and Washington, pharmacists can provide both testing and antiviral treatment during one appointment. Flu and COVID-19 tests cost $29.99, with pharmacist assessments priced at $45. CVS also offers at-home test kits and prescription delivery options. Updated flu and COVID-19 vaccines remain available at CVS Pharmacy and MinuteClinic locations nationwide.
CVS is currently trading at $64.72 up 1.35 percent or $0.86 on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
August 21, 2026 14:42 ET The minutes of the latest policy meeting of the Federal Reserve, housing market data and manufacturing sector survey results were the main news for the U.S. economy this week. In Europe, inflation data from the U.K. was the highlight, while consumer price data from Japan drew attention in Asia.